5632-17-7

Basic information

• Product Name: 4-Chloromethylquinoline
• Synonyms: 4-Chloromethylquinoline;4-ChloroMethylquinoline hydrochloride;Quinoline, 4-(chloroMethyl)-;4-Chloromethylquinoline HCl
• CAS NO: 5632-17-7
• Molecular Formula: C₁₀H₈ClN
• Molecular Weight: 177.63
• Mol File: 5632-17-7.mol
• Article Data: 8

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 4-Chloromethylquinoline(CAS DataBase Reference)
• NIST Chemistry Reference: 4-Chloromethylquinoline(5632-17-7)
• EPA Substance Registry System: 4-Chloromethylquinoline(5632-17-7)

Safety Data

• Hazardous Substances Data: 5632-17-7(Hazardous Substances Data)

Usage

General Description

4-Chloromethylquinoline, also known as 4-chloromethyl-1-methylquinoline, is an organic compound that belongs to the class of quinoline derivatives. It is a yellow liquid with a strong, unpleasant odor. 4-Chloromethylquinoline is used primarily as an intermediate in the synthesis of pharmaceuticals, agrochemicals, and other organic compounds. It has also been studied for its potential antitumor and antimalarial activities. 4-Chloromethylquinoline is known to be irritant to the skin, eyes, and respiratory system, and should be handled and used with caution in laboratory and industrial settings.

Upstream product

• 5632-16-6 4-(bromomethyl)quinoline 
• 4053-40-1 4-methylquinoline 1-oxide 
• 109-63-7 trifluoroborane diethyl ether 
• 68-12-2 N,N-dimethyl-formamide 
• 98-59-9 p-toluenesulfonyl chloride 
• 7647-01-0 hydrogenchloride 
• 491-35-0 C₆H₄NCH₂CHCCH₂ 
• 6281-32-9 4-quinolylmethanol 
• 634-47-9 2-chloro-4-methylquinoline 
• 4876-10-2 2-hydroxy-4-bromomethylquinoline 
• 137354-54-2 4-(bromomethyl)-2-chloroquinoline 
• 432518-08-6 2-chloro-4-(hydroxymethyl)quinoline 
• 1205-74-9 4-bromo-3-oxo-N-phenylbutanamide 
• 874499-04-4 acetic acid-(2-chloro-[4]quinolylmethyl ester) 

Downstream Products

• 14003-46-4 2-(quinolin-4-yl)acetonitrile 
• 1043593-34-5 5-(2-(quinolin-4-yl)methoxyphenyl)-N-(3-trifluoromethylphenyl)-1,3,4-oxadiazol-2-amine 
• 1043592-19-3 N-phenyl-5-(2-(quinolin-4-yl)methylthiophenyl)-1,3,4-oxadiazol-2-amine 
• 1524735-13-4 2-(quinolin-4-ylmethoxy)benzaldehyde 
• 1062368-21-1 4-quinolin-4-yl-2H-pyrazol-3-ylamine 
• 1062368-22-2 C₂₁H₁₃BrN₄ 
• 1062368-24-4 LDN-193189 
• 1062368-23-3 C₃₃H₂₈N₆O₂ 
• 1187313-01-4 C₂₆H₂₃N₅ 
• 1187313-00-3 C₂₇H₂₅N₅O 
• 1187313-20-7 C₃₁H₃₁N₅O₂ 
• 1187313-18-3 C₃₁H₂₉N₅O₂ 
• 1187313-23-0 C₃₁H₃₁N₅O₃ 
• 1187313-12-7 C₃₂H₃₃N₅O₃ 

Relevant articles and documents

THIAZOLE DERIVATIVES AS PROTEIN SECRETION INHIBITORS

Provided herein are secretion inhibitors, such as inhibitors of Sec61, methods for their preparation, related pharmaceutical compositions, and methods for using the same, wherein the compound has a structure of Formula (I), (II), or (III).

INHIBITORS OF THE BMP SIGNALING PATHWAY

The present invention provides small molecule inhibitors of BMP signaling. These compounds may be used to modulate cell growth, differentiation, proliferation, and apoptosis, and thus may be useful for treating diseases or conditions associated with BMP signaling, including inflammation, cardiovascular disease, hematological disease, cancer, and bone disorders, as well as for modulating cellular differentiation and/or proliferation.

NOVEL CYCLIC COMPOUND HAVING QUINOLYLALKYLTHIO GROUP

The present invention relates to a synthesis study of novel cyclic compounds having a quinolylalkylthio group represented by the formula (1), and pharmacological actions of the compounds. In the formula, the ring X represents: which may have halogen and/or alkyl; R1 and R2 independently represent hydrogen, alkyl, cycloalkyl, aryl or a (non) aromatic heterocycle; R3 represents qinolyl; A represents sulfur, sulfinyl or sulfonyl; and B represents alkylene.